Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Thomas Elmer Witzig
2020

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Hampel, P. J., Call, T. G., Ding, W., Muchtar, E., Kenderian, S. S., Wang, Y., Leis, J. F., Witzig, T. E., Koehler, A. B., Fonder, A. L., Schwager, S. M., Rabe, K. G., Van Dyke, D. L., Braggio, E., Slager, S. L., Kay, N. E. & Parikh, S. A., Mar 1 2020, In : American journal of hematology. 95, 3, p. E57-E60

Research output: Contribution to journalLetter

Open Access

Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma

St-Pierre, F., Broski, S. M., LaPlant, B. R., Maurer, M. J., Ristow, K., Thanarajasingam, G., Macon, W. R., Habermann, T. M. & Witzig, T. E., 2020, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access

Hypomagnesemia is associated with an increased risk of early clinical failure in patients with Burkitt lymphoma

Gile, J., Ruan, G., Abeykoon, J., McMahon, M. M., Macon, W. R. & Witzig, T. E., 2020, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

Zanwar, S., Abeykoon, J. P., Durot, E., King, R., Perez Burbano, G. E., Kumar, S., Gertz, M. A., Quinquenel, A., Delmer, A., Gonsalves, W., Cornillet-Lefebvre, P., He, R., Warsame, R., Buadi, F. K., Novak, A. J., Greipp, P. T., Inwards, D., Habermann, T. M., Micallef, I., Go, R. & 19 others, Muchtar, E., Kourelis, T., Dispenzieri, A., Lacy, M. Q., Dingli, D., Nowakowski, G., Thompson, C. A., Johnston, P., Thanarajasingam, G., Bennani, N. N., Witzig, T. E., Villasboas, J., Leung, N., Lin, Y., Kyle, R. A., Rajkumar, S. V., Ansell, S. M., Le-Rademacher, J. G. & Kapoor, P., Mar 1 2020, In : American journal of hematology. 95, 3, p. 274-281 8 p.

Research output: Contribution to journalArticle

3 Scopus citations

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

Thanarajasingam, G., Leonard, J. P., Witzig, T. E., Habermann, T. M., Blum, K. A., Bartlett, N. L., Flowers, C. R., Pitcher, B. N., Jung, S. H., Atherton, P. J., Tan, A., Novotny, P. J. & Dueck, A. C., Jun 2020, In : The Lancet Haematology. 7, 6, p. e490-e497

Research output: Contribution to journalReview article

Magnesium: The overlooked electrolyte in blood cancers?

Gile, J., Ruan, G., Abeykoon, J., McMahon, M. M. & Witzig, T., 2020, (Accepted/In press) In : Blood Reviews. 100676.

Research output: Contribution to journalReview article

1 Scopus citations

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 28 2020, In : Leukemia and Lymphoma. 61, 2, p. 318-327 10 p.

Research output: Contribution to journalArticle

1 Scopus citations

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

Hartert, K. T., Wenzl, K., Krull, J. E., Manske, M., Sarangi, V., Asmann, Y., Larson, M. C., Maurer, M. J., Slager, S., Macon, W. R., King, R. L., Feldman, A. L., Gandhi, A. K., Link, B. K., Habermann, T. M., Yang, Z. Z., Ansell, S. M., Cerhan, J. R., Witzig, T. E., Nowakowski, G. S. & 1 others, Novak, A. J., 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma

Nowakowski, G. S., Chiappella, A., Witzig, T. E., Scott, D. W., Spina, M., Gascoyne, R. D., Zhang, L., Russo, J., Kang, J., Zhang, J., Xu, Y. & Vitolo, U., Jan 31 2020, In : Haematologica. 105, 2, p. E72-E75

Research output: Contribution to journalLetter

Open Access
1 Scopus citations
2019

Acalabrutinib for mantle cell lymphoma

Witzig, T. E. & Inwards, D., Jan 1 2019, In : Blood. 133, 24, p. 2570-2574 5 p.

Research output: Contribution to journalArticle

3 Scopus citations

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma

Shenoy, N., Bhagat, T. D., Cheville, J., Lohse, C., Bhattacharyya, S., Tischer, A., Machha, V., Gordon-Mitchell, S., Choudhary, G., Wong, L. F., Gross, L. A., Ressigue, E., Leibovich, B., Boorjian, S. A., Steidl, U., Wu, X., Pradhan, K., Gartrell, B., Agarwal, B., Pagliaro, L. & 8 others, Suzuki, M., Greally, J. M., Rakheja, D., Houston Thompson, R., Susztak, K., Witzig, T., Zou, Y. & Verma, A., Apr 1 2019, In : Journal of Clinical Investigation. 129, 4, p. 1612-1625 14 p.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

Sahin, I., Kawano, Y., Sklavenitis-Pistofidis, R., Moschetta, M., Mishima, Y., Manier, S., Sacco, A., Carrasco, R., Fonseca, R., Roccaro, A. M., Witzig, T. & Ghobrial, I. M., Apr 9 2019, In : Blood Advances. 3, 7, p. 995-1002 8 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma

St-Pierre, F., Broski, S. M., LaPlant, B. R., Ristow, K., Maurer, M. J., Macon, W. R., Habermann, T. M., Ansell, S. M., Thompson, C. A., Micallef, I. N. M., Nowakowski, G. S. & Witzig, T. E., Jul 2019, In : American journal of hematology. 94, 7, p. 786-793 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

DNA demethylation and epigenetics

Zhang, X., Witzig, T. E. & Wu, X., Jan 5 2019, Handbook of Nutrition, Diet, and Epigenetics. Springer International Publishing, Vol. 1. p. 281-292 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Erratum: Phase I trial of rituximab, cladribine, and temsirolimus (rct) for initial therapy of mantle cell lymphoma (Annals of Oncology (2014) 25 (2020-2024) DOI: 10.1093/annonc/mdu273)

Inwards, D. J., Fishkin, P. A., Laplant, B. R., Drake, M. T., Kurtin, P. J., Nikcevich, D. A., Wender, D. B., Lair, B. S. & Witzig, T. E., Feb 1 2019, In : Annals of Oncology. 30, 2, 1 p.

Research output: Contribution to journalComment/debate

Open Access

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jun 2019, In : American journal of hematology. 94, 6, p. E153-E155

Research output: Contribution to journalLetter

Open Access
7 Scopus citations

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Wang, Y., Link, B. K., Witzig, T. E., Maurer, M. J., Allmer, C., King, R. L., Feldman, A. L., Habermann, T. M., Ansell, S. M., Slager, S. L., Cerhan, J. R. & Nowakowski, G. S., Oct 17 2019, In : Blood. 134, 16, p. 1289-1297 9 p.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations
2 Scopus citations

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

Nowakowski, G. S., Feldman, T., Rimsza, L. M., Westin, J. R., Witzig, T. E. & Zinzani, P. L., Jun 1 2019, In : Blood cancer journal. 9, 6, 48.

Research output: Contribution to journalReview article

Open Access
4 Scopus citations

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

Primary Cutaneous Acral CD8+ T-Cell Lymphoma-A Single Center Review of 3 Cases and Recent Literature Review

Tjahjono, L. A., Davis, M. D. P., Witzig, T. E. & Comfere, N. I., Sep 1 2019, In : The American Journal of dermatopathology. 41, 9, p. 644-648 5 p.

Research output: Contribution to journalReview article

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Hampel, P. J., Ding, W., Call, T. G., Rabe, K. G., Kenderian, S. S., Witzig, T. E., Muchtar, E., Leis, J. F., Chanan-Khan, A. A., Koehler, A. B., Fonder, A. L., Schwager, S. M., Slager, S. L., Shanafelt, T. D., Kay, N. E. & Parikh, S. A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

4 Scopus citations
6 Scopus citations

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Wu, X., Stenson, M., Abeykoon, J., Nowakowski, K., Zhang, L., Lawson, J., Wellik, L., Li, Y., Krull, J., Wenzl, K., Novak, A. J., Ansell, S. M., Bishop, G. A., Billadeau, D. D., Peng, K. W., Giles, F., Schmitt, D. M. & Witzig, T. E., Jul 25 2019, In : Blood. 134, 4, p. 363-373 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells

Abeykoon, J. P., Paludo, J., Nowakowski, K. E., Stenson, M. J., King, R., Wellik, L. E., Wu, X. & Witzig, T. E., Mar 1 2019, In : Blood cancer journal. 9, 3, 24.

Research output: Contribution to journalLetter

Open Access
2 Scopus citations

Work-Life Balance Solutions for Physicians—It's All About You, Your Work, and Others

Witzig, T. E. & Smith, S. M., Apr 1 2019, In : Mayo Clinic proceedings. 94, 4, p. 573-576 4 p.

Research output: Contribution to journalShort survey

2 Scopus citations
2018

Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes

Park, J. Y., Guo, W., Al-Hijji, M., El Sabbagh, A., Begna, K., Habermann, T. M., Witzig, T. E., Lewis, B. R., Lerman, A. & Herrmann, J., Jan 1 2018, (Accepted/In press) In : International Journal of Cardiology.

Research output: Contribution to journalArticle

8 Scopus citations

Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: Final results from the PILLAR-2 randomized phase III trial

Witzig, T. E., Tobinai, K., Rigacci, L., Ikeda, T., Vanazzi, A., Hino, M., Shi, Y., Mayer, J., Costa, L. J., Bermudez Silva, C. D., Zhu, J., Belada, D., Bouabdallah, K., Kattan, J. G., Kuruvilla, J., Kim, W. S., Larouche, J. F., Ogura, M., Ozcan, M., Fayad, L. & 5 others, Wu, C., Fan, J., Louveau, A. L., Voi, M. & Cavalli, F., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 707-714 8 p.

Research output: Contribution to journalArticle

15 Scopus citations

A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers

Tolcher, A., Flaherty, K., Shapiro, G. I., Berlin, J., Witzig, T., Habermann, T., Bullock, A., Rock, E., Elekes, A., Lin, C., Kostic, D., Ohi, N., Rasco, D., Papadopoulos, K. P., Patnaik, A., Smith, L. & Cote, G. M., Jun 2018, In : Oncologist. 23, 6, p. 658-e72

Research output: Contribution to journalArticle

18 Scopus citations

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A. C., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C. B., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly

Shenoy, N., Creagan, E., Witzig, T. E. & Levine, M., Nov 12 2018, In : Cancer Cell. 34, 5, p. 700-706 7 p.

Research output: Contribution to journalReview article

31 Scopus citations

Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?

Shenoy, N., Mudireddy, M., Vallapureddy, R., Leung, N., Pagliaro, L., Witzig, T. E., Ou, F-S., Ordog, T., Cheville, J., Patnaik, M. M., Thompson, R. H., Tefferi, A. & Begna, K., Jan 1 2018, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

17 Scopus citations

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T., Vitolo, U. & Nowakowski, G. S., Jul 1 2018, In : Blood cancer journal. 8, 7, 63.

Research output: Contribution to journalArticle

6 Scopus citations

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I. N., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

30 Scopus citations
3 Scopus citations

History of autoimmune conditions and lymphoma prognosis

Kleinstern, G., Maurer, M. J., Liebow, M., Habermann, T. M., Koff, J. L., Allmer, C., Witzig, T. E., Nowakowski, G. S., Micallef, I., Johnston, P. B., Inwards, D. J., Thompson, C. A., Feldman, A. L., Link, B. K., Flowers, C., Slager, S. L. & Cerhan, J. R., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 73.

Research output: Contribution to journalArticle

4 Scopus citations

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

McPhail, E. D., Maurer, M. J., Macon, W. R., Feldman, A. L., Kurtin, P. J., Ketterling, R. P., Vaidya, R., Cerhan, J. R., Ansell, S. M., Porrata, L. F., Nowakowski, G. S., Witzig, T. E. & Habermann, T. M., Oct 31 2018, In : Haematologica. 103, 11, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, G., Habermann, T. M. & 3 others, Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Nov 1 2018, In : Blood cancer journal. 8, 11, 108.

Research output: Contribution to journalArticle

8 Scopus citations

Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma

Wenzl, K., Manske, M. K., Sarangi, V., Asmann, Y., Greipp, P. T., Schoon, H. R., Braggio, E. D., Maurer, M. J., Feldman, A. L., Witzig, T. E., Slager, S. L., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Oct 1 2018, In : Blood Cancer Journal. 8, 10, 97.

Research output: Contribution to journalArticle

7 Scopus citations

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

Abeykoon, J. P., Paludo, J., King, R., Ansell, S. M., Gertz, M., LaPlant, B. R., Halvorson, A. E., Gonsalves, W., Dingli, D. M., Fang, H., Rajkumar, S. V., Lacy, M., He, R., Kourelis, T., Reeder, C. B., Novak, A. J., McPhail, E., Viswanatha, D. S., Witzig, T. E., Go, R. S. & 10 others, Habermann, T. M., Buadi, F. K., Dispenzieri, A., Leung, N., Lin, Y., Thompson, C. A., Hayman, S. R., Kyle, R. A., Kumar, S. K. & Kapoor, P., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 187-194 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Outcomes among North American patients with diffuse large b-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

Tracy, S. I., Habermann, T. M., Feldman, A. L., Maurer, M. J., Dogan, A., Perepu, U. S., Syrbu, S., Ansell, S. M., Thompson, C. A., Weiner, G. J., Nowakowski, G. S., Allmer, C., Slager, S. L., Witzig, T. E., Cerhan, J. R. & Link, B. K., Jan 31 2018, In : Haematologica. 103, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Tun, H. W., Johnston, P. B., DeAngelis, L. M., Atherton, P. J., Pederson, L. D., Koenig, P. A., Reeder, C. B., Padula Omuro, A. M., Schiff, D., O'Neill, B., Pulido, J., Jaeckle, K. A., Grommes, C. & Witzig, T. E., Nov 22 2018, In : Blood. 132, 21, p. 2240-2248 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

Abeykoon, J. P., Zanwar, S., Ansell, S. M., Winters, J., Gertz, M. A., King, R. L., Murray, D., Habermann, T., Dingli, D., Muchtar, E., Go, R. S., Leung, N., Inwards, D. J., Buadi, F. K., Dispenzieri, A., Lacy, M. Q., Lin, Y., Gonsalves, W. I., Kourelis, T., Witzig, T. E. & 5 others, Thompson, C., Vincent Rajkumar, S., Kyle, R. A., Kumar, S. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

4 Scopus citations

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Zanwar, S., Abeykoon, J. P., Ansell, S. M., Gertz, M. A., Dispenzieri, A., Muchtar, E., Sidana, S., Tandon, N., Rajkumar, S. V., Dingli, D., Go, R. S., Lacy, M. Q., Kourelis, T., Witzig, T. E., Inwards, D., Buadi, F., Gonsalves, W., Habermann, T., Johnston, P., Nowakowski, G. & 3 others, Kyle, R. A., Kumar, S. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

5 Scopus citations

Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma

Han, J. J., O’byrne, M., Stenson, M. J., Maurer, M. J., Wellik, L. E., Feldman, A. L., McPhail, E. D., Witzig, T. E. & Gupta, M. D., Nov 1 2018, In : Blood cancer journal. 8, 11, 110.

Research output: Contribution to journalArticle

7 Scopus citations